ESG Investing: Cure-all or Placebo?
Oct 20, 2021 • Kenan Insight
With more business leaders than ever before embracing stakeholder capitalism – or the belief that companies should work to benefit all stakeholders, not just shareholders – myriad questions have arisen about the concept’s viability and potential for impact. The Kenan Institute has been working to respond, and today we are excited to launch a new series exploring the most pressing issues surrounding stakeholder capitalism. Kicking off the series is this week’s Kenan Insight, which takes a deeper dive into the buzzed-about world of ESG investing. We hope you’ll check it out, and look forward to engaging with you on this topic and others throughout the series!